strontium(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases vertebral fracture incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“Strontium ranelate was associated with a reduction in the relative risk of vertebral fracture, relative to placebo, of 40% (RR = 0.60, 95% CI [0.53–0.70], p < 0.001).”
Quoted verbatim from Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.. - Study
- RCT
- Dose
- strontium ranelate 2 g/day
- Population
- Post-menopausal women with osteoporosis, pooled from the SOTI and TROPOS randomised placebo-controlled trials; calcium and vitamin D supplements given to both arms; 3-year vertebral fracture data
Effect 0.6 risk ratio, 95% CI 0.53 to 0.7
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.2010PMID:19436941Permalink
Keep reading
- Everything the graph holds on strontium(2+)
- Every compound studied against Vertebral fracture incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5N0YJ99DSTK8J4FEX2HDMMV